CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Radiation Therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01540994
NCT01540994N/ACompleted
CompareCT.gov

Phase I/II Trial of Stereotactic Hypofractionated Radiotherapy of the Prostate

Sharp HealthCare·interventional·Posted Feb 29, 2012·Updated Jan 16, 2025

In Brief

A clinical study evaluating Radiation Therapy for Prostatic Neoplasm. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate a short course (five radiation treatments) of very focused ("stereotactic") external beam radiation therapy for the treatment of early stage prostate cancer.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstatic Neoplasm
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 29, 2012
Enrollment StartJan 1, 2011
Primary CompletionApr 5, 2019
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 14.3 years ago

Interventions

Radiation Therapyradiation

Stereotactic Body Radiation Therapy